These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25122690)

  • 1. Cost-effective master cell bank validation of multiple clinical-grade human pluripotent stem cell lines from a single donor.
    Devito L; Petrova A; Miere C; Codognotto S; Blakely N; Lovatt A; Ogilvie C; Khalaf Y; Ilic D
    Stem Cells Transl Med; 2014 Oct; 3(10):1116-24. PubMed ID: 25122690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.
    Rao MS; Pei Y; Garcia TY; Chew S; Kasai T; Hisai T; Taniguchi H; Takebe T; Lamba DA; Zeng X
    Cytotherapy; 2018 Jun; 20(6):861-872. PubMed ID: 29793831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and validation of a good manufacturing practice grade human fibroblast line for supporting human embryonic stem cell derivation and culture.
    Prathalingam N; Ferguson L; Young L; Lietz G; Oldershaw R; Healy L; Craig A; Lister H; Binaykia R; Sheth R; Murdoch A; Herbert M
    Stem Cell Res Ther; 2012 Mar; 3(2):12. PubMed ID: 22472092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.
    Shafa M; Walsh T; Panchalingam KM; Richardson T; Menendez L; Tian X; Suresh Babu S; Dadgar S; Beller J; Yang F; Baghbaderani BA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient derivation and banking of clinical-grade human embryonic stem cell lines in accordance with Japanese regulations.
    Takada K; Nakatani R; Moribe E; Yamazaki-Fujigaki S; Fujii M; Furuta M; Suemori H; Kawase E
    Regen Ther; 2022 Dec; 21():553-559. PubMed ID: 36397823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Korea National Stem Cell Bank.
    Kim JH; Jo HY; Ha HY; Kim YO
    Stem Cell Res; 2021 May; 53():102270. PubMed ID: 33714852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances.
    Chhabra A
    Stem Cell Rev Rep; 2017 Dec; 13(6):757-773. PubMed ID: 28918520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.
    Baghbaderani BA; Syama A; Sivapatham R; Pei Y; Mukherjee O; Fellner T; Zeng X; Rao MS
    Stem Cell Rev Rep; 2016 Aug; 12(4):394-420. PubMed ID: 27283945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of mice derived from induced pluripotent stem cells.
    Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
    J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
    Ausubel LJ; Lopez PM; Couture LA
    Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hadassah, provider of "Regulatory-Ready" pluripotent clinical-grade stem cell banks.
    Tannenbaum SE; Singer O; Gil Y; Berman-Zaken Y; Ilouz N; Khaner H; Haimov M; Reubinoff BE
    Stem Cell Res; 2020 Jan; 42():101670. PubMed ID: 31838378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The generation of GLP-grade human embryonic stem cell banks from four clinical-grade cell lines for preclinical research.
    Sivarajah S; Raj GS; Mathews AJ; Sahib NB; Hwang WS; Crook JM
    In Vitro Cell Dev Biol Anim; 2010 Apr; 46(3-4):210-6. PubMed ID: 20177998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy.
    Rehakova D; Souralova T; Koutna I
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray.
    He W; Kang X; Du H; Song B; Lu Z; Huang Y; Wang D; Sun X; Yu Y; Fan Y
    PLoS One; 2014; 9(9):e108350. PubMed ID: 25250679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
    Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
    Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.
    Awe JP; Lee PC; Ramathal C; Vega-Crespo A; Durruthy-Durruthy J; Cooper A; Karumbayaram S; Lowry WE; Clark AT; Zack JA; Sebastiano V; Kohn DB; Pyle AD; Martin MG; Lipshutz GS; Phelps PE; Pera RA; Byrne JA
    Stem Cell Res Ther; 2013 Jul; 4(4):87. PubMed ID: 23890092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological considerations for embryonic and induced pluripotent stem cell banking.
    Taylor CJ; Bolton EM; Bradley JA
    Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2312-22. PubMed ID: 21727137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and approaches to the culture of pluripotent human embryonic stem cells.
    Skottman H; Narkilahti S; Hovatta O
    Regen Med; 2007 May; 2(3):265-73. PubMed ID: 17511563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can cord blood banks transform into induced pluripotent stem cell banks?
    Zhou H; Rao MS
    Cytotherapy; 2015 Jun; 17(6):756-764. PubMed ID: 25770678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.